BIOMAT Database Logo BIOMAT Database Logo

Sympathomimetic agents and airway hyperreactivity. 1993

K Hoshiko, and I D Chapman, and J Morley

UI MeSH Term Description Entries
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas
D013566 Sympathomimetics Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. Amines, Sympathomimetic,Sympathomimetic,Sympathomimetic Agent,Sympathomimetic Drug,Sympathomimetic Agents,Sympathomimetic Drugs,Sympathomimetic Effect,Sympathomimetic Effects,Agent, Sympathomimetic,Agents, Sympathomimetic,Drug, Sympathomimetic,Drugs, Sympathomimetic,Effect, Sympathomimetic,Effects, Sympathomimetic,Sympathomimetic Amines
D016085 Bronchoconstrictor Agents Agents causing the narrowing of the lumen of a bronchus or bronchiole. Bronchial-Constricting Agents,Bronchoconstrictor Effect,Bronchoconstrictor Effects,Bronchoconstrictors,Agents, Bronchial-Constricting,Agents, Bronchoconstrictor,Bronchial Constricting Agents,Effect, Bronchoconstrictor,Effects, Bronchoconstrictor
D016535 Bronchial Hyperreactivity Tendency of the smooth muscle of the tracheobronchial tree to contract more intensely in response to a given stimulus than it does in the response seen in normal individuals. This condition is present in virtually all symptomatic patients with asthma. The most prominent manifestation of this smooth muscle contraction is a decrease in airway caliber that can be readily measured in the pulmonary function laboratory. Bronchial Hyperreactivities,Hyperreactivities, Bronchial,Hyperreactivity, Bronchial

Related Publications

K Hoshiko, and I D Chapman, and J Morley
[Airway hyperreactivity].
January 2011, Ceskoslovenska fysiologie,
K Hoshiko, and I D Chapman, and J Morley
Airway hyperreactivity.
July 1988, Lancet (London, England),
K Hoshiko, and I D Chapman, and J Morley
[Airway hyperreactivity and airway epithelial function].
May 1989, Kokyu to junkan. Respiration & circulation,
K Hoshiko, and I D Chapman, and J Morley
[SYMPATHOMIMETIC AGENTS].
October 1963, [Sogo rinsho] Clinic all-round,
K Hoshiko, and I D Chapman, and J Morley
Sympathomimetics and airway hyperreactivity.
November 1994, Thorax,
K Hoshiko, and I D Chapman, and J Morley
PAF and airway hyperreactivity.
August 1985, Lancet (London, England),
K Hoshiko, and I D Chapman, and J Morley
Gold nanoparticles and airway hyperreactivity.
August 2011, The European respiratory journal,
K Hoshiko, and I D Chapman, and J Morley
Mucosal oedema and airway hyperreactivity.
June 1989, The European respiratory journal. Supplement,
K Hoshiko, and I D Chapman, and J Morley
Antiasthma drugs and airway hyperreactivity.
January 1992, The American review of respiratory disease,
K Hoshiko, and I D Chapman, and J Morley
Eosinophil accumulation and airway hyperreactivity.
June 1996, The European respiratory journal,
Copied contents to your clipboard!